FR2627986B1 - Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one ou d'un de ses sels et de dexamethasone, son procede de preparation et ses utilisations - Google Patents

Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one ou d'un de ses sels et de dexamethasone, son procede de preparation et ses utilisations

Info

Publication number
FR2627986B1
FR2627986B1 FR898902779A FR8902779A FR2627986B1 FR 2627986 B1 FR2627986 B1 FR 2627986B1 FR 898902779 A FR898902779 A FR 898902779A FR 8902779 A FR8902779 A FR 8902779A FR 2627986 B1 FR2627986 B1 FR 2627986B1
Authority
FR
France
Prior art keywords
methyl
carbazol
imidazol
dexamethasone
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR898902779A
Other languages
English (en)
Other versions
FR2627986A1 (fr
Inventor
Brian Tyers Michael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10632894&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2627986(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FR2627986A1 publication Critical patent/FR2627986A1/fr
Application granted granted Critical
Publication of FR2627986B1 publication Critical patent/FR2627986B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR898902779A 1988-03-04 1989-03-03 Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one ou d'un de ses sels et de dexamethasone, son procede de preparation et ses utilisations Expired - Lifetime FR2627986B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805269A GB8805269D0 (en) 1988-03-04 1988-03-04 Medicaments

Publications (2)

Publication Number Publication Date
FR2627986A1 FR2627986A1 (fr) 1989-09-08
FR2627986B1 true FR2627986B1 (fr) 1994-03-04

Family

ID=10632894

Family Applications (1)

Application Number Title Priority Date Filing Date
FR898902779A Expired - Lifetime FR2627986B1 (fr) 1988-03-04 1989-03-03 Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one ou d'un de ses sels et de dexamethasone, son procede de preparation et ses utilisations

Country Status (23)

Country Link
US (2) US6544550B1 (fr)
JP (1) JPH0296525A (fr)
KR (1) KR890014109A (fr)
AT (1) AT400301B (fr)
AU (1) AU626010B2 (fr)
BE (1) BE1002255A5 (fr)
CA (1) CA1319323C (fr)
CH (1) CH678149A5 (fr)
CY (1) CY1634A (fr)
CZ (1) CZ402391A3 (fr)
DE (1) DE3906883C2 (fr)
DK (1) DK175428B1 (fr)
FR (1) FR2627986B1 (fr)
GB (2) GB8805269D0 (fr)
HK (1) HK41792A (fr)
IE (1) IE61516B1 (fr)
IT (1) IT1232662B (fr)
NL (1) NL194463C (fr)
NZ (1) NZ228214A (fr)
SE (1) SE508342C2 (fr)
SG (1) SG9092G (fr)
SK (1) SK402391A3 (fr)
ZA (1) ZA891639B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929059A (en) * 1991-01-19 1999-07-27 Smithkline Beecham P.L.C. Pharmaceutical compositions containing granisetron and dexamethasone
GB9101221D0 (en) * 1991-01-19 1991-02-27 Smithkline Beecham Plc Pharmaceuticals
EP0916346A3 (fr) * 1991-09-20 2000-12-06 Glaxo Group Limited Recepteurs antagonistes NK-1 et recepteurs antagonistes 5HT3 pour le traitement des vomissements
KR960700711A (ko) * 1993-03-08 1996-02-24 후지야마 아키라 뇌혈관성 질환의 치료 또는 예방용 약제(Medicament for treating or preventing cerebrovascular diseases)
US5661142A (en) * 1996-04-17 1997-08-26 Naeger; David M. Anti-emetic composition
WO2005108392A2 (fr) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Procede de preparation de chlorhydrate dihydrate d'ondansetron ayant une granulometrie definie
US20050277624A1 (en) * 2004-06-09 2005-12-15 Nigel Cook Use of corticosteroids alone or in conjunction with nutritional therapy to reduce stress in animals
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920003064B1 (ko) * 1984-01-25 1992-04-13 글락소 그룹 리미티드 헤테로시클릭 화합물의 제조방법
DE3680123D1 (en) * 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.
EP0201165B1 (fr) * 1985-03-14 1994-07-20 Beecham Group Plc Médicaments pour le traitement de l'éméticité
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
DK662687A (da) * 1986-12-17 1988-06-18 Glaxo Group Ltd Anvendelse af tricycliske carbazoloner
US4920219A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
US5246709A (en) * 1990-09-10 1993-09-21 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
KR890014109A (ko) 1989-10-21
DE3906883C2 (de) 1998-11-05
NZ228214A (en) 1997-02-24
CH678149A5 (fr) 1991-08-15
US5482716A (en) 1996-01-09
GB8904881D0 (en) 1989-04-12
CY1634A (en) 1992-11-06
DK104389D0 (da) 1989-03-03
SK402391A3 (en) 2000-12-11
JPH0296525A (ja) 1990-04-09
ATA48389A (de) 1995-04-15
AU626010B2 (en) 1992-07-23
GB2216414B (en) 1991-12-11
DK104389A (da) 1989-09-05
IT8947713A0 (it) 1989-03-03
FR2627986A1 (fr) 1989-09-08
SE508342C2 (sv) 1998-09-28
CA1319323C (fr) 1993-06-22
SE8900751L (sv) 1989-09-05
SG9092G (en) 1992-03-20
ZA891639B (en) 1990-03-28
AU3097689A (en) 1989-09-07
CZ402391A3 (en) 1993-04-14
GB2216414A (en) 1989-10-11
DK175428B1 (da) 2004-10-18
GB8805269D0 (en) 1988-04-07
NL194463C (nl) 2002-05-03
HK41792A (en) 1992-06-19
DE3906883A1 (de) 1989-09-14
IE890697L (en) 1989-09-04
NL194463B (nl) 2002-01-02
IT1232662B (it) 1992-03-02
SE8900751D0 (sv) 1989-03-03
AT400301B (de) 1995-12-27
IE61516B1 (en) 1994-11-16
NL8900526A (nl) 1989-10-02
BE1002255A5 (fr) 1990-11-06
US6544550B1 (en) 2003-04-08

Similar Documents

Publication Publication Date Title
OA09198A (fr) "Comprimés de cholestyramine et procédé pour les préparer".
FR2633181B1 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
PT88268A (pt) Procede et dispositif d'elaboration de verre fondu
BE1003835B5 (fr) Dispositif d'administration.
FR2724461B1 (fr) Microsphere de latex biotinylee, procede de preparation d'une telle microsphere et utilisation en tant qu'agent de detection biologique
FR2604255B1 (fr) Dispositif et procede pour realiser la pesee d'articles postaux
BE890002A (fr) Procede d'acceleration de la dissolution de substances medicamenteuses lyophilisees difficilement solubles
FR2583616B1 (fr) Dispositif de conditionnement fonctionnel pour mise en place d'un insecticide et produit utilise.
FR2650806B1 (fr) Procede et dispositif d'amenee de bouteilles
MA22443A1 (fr) Procede de preparation d'une composition pharmaceutique .
FR2627986B1 (fr) Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one ou d'un de ses sels et de dexamethasone, son procede de preparation et ses utilisations
NO881545D0 (no) Nye pyrrolidin-2-(1,3-dikarbonyl)-derivater, samt fremgangsmaate for fremstilling derav.
FR2635550B1 (fr) Procede de surelevation d'immeubles
FR2630735B1 (fr) Procede de preparations d'halogenophenols
FR2633273B1 (fr) Procede de preparation de tetraflurorure d'uranium
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
FR2637512B1 (fr) Dispositif de delivrance automatique d'un produit ou d'un objet quelconque
FR2632952B1 (fr) Procede de preparation d'isocyanates d'arylsulfonyle et des derives d'addition en resultant
FR2657872B2 (fr) Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
FR2558828B1 (fr) " 1a,25-dihydroxy-22z-deshydrovitamine d " composition pharmaceutique et procede de preparation
FR2607678B3 (fr) Dispositif de lacage d'articles chaussants
TR27462A (tr) Sübstitüe edilmis sinamik asidi hidroksiamid'leri, bunlarin üretilmesine mahsus usul, bunlari ihtiva eden maddeler ve bunlarin kullanilmasi.
MA19021A1 (fr) Procede de preparation de compositions pharmaceutiques a base d'alpha-12-bis(i methyl ethyl)amino/alpha-phenyl 2-pyridine acetamide ou de l'un de ses sels
FR2668707B1 (fr) Procede de preparation d'une composition pharmaceutique.